✦ LIBER ✦

CYP2D6 genotyping for psychiatric patients treated with risperidone: considerations for cost–effectiveness studies

✍ Scribed by Rodríguez-Antona, Cristina; Gurwitz, David; de Leon, Jose; Llerena, Adrián; Kirchheiner, Julia; de Mesa, Emma Gutiérrez; Ibarreta, Dolores

Book ID: 117999010
Publisher: Future Medicine
Year: 2009
Tongue: English
Weight: 923 KB
Volume: 10
Category: Article
ISSN: 1462-2416
DOI: 10.2217/pgs.09.15

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effects of psychopharmacotherapy on phen

Effects of psychopharmacotherapy on phenotypic expression of cytochrome P450 2D6 in patients genotyped for CYP2D6 mutations

✍ O Zelenková; E Hadasová; E Česková; M Vojtísková; M Hyksová 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 49 KB 👁 1 views

No Abstract

DoCYP2D6genotypes reflect oxycodone requ

DoCYP2D6genotypes reflect oxycodone requirements for cancer patients treated for cancer pain? A cross-sectional multicentre study

✍ Trine Naalsund Andreassen; Ingrid Eftedal; Pål Klepstad; Andrew Davies; Kristin 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 263 KB

Treatment effectiveness and adherence in

Treatment effectiveness and adherence in patients with schizophrenia treated with risperidone long-acting injection

✍ Chen-Lin Chang; Dong-Sheng Tzeng; For-Wey Lung 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 148 KB

PUK23 METHODOLOGICAL CONSIDERATIONS FOR

PUK23 METHODOLOGICAL CONSIDERATIONS FOR COST-EFFECTIVENESS ANALYSIS OF ONABOTULINUMTOXINA IN PATIENTS WITH NEUROGENIC DETRUSOR OVERACTIVITY

✍ D. Globe; J. Carlson; H. Patel; D. Colayco; R.N. Hansen; J. Watanabe; S.D. Sulli 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB

CYP2D6is a major determinant of metoprol

CYP2D6is a major determinant of metoprolol disposition and effects in hospitalized Russian patients treated for acute myocardial infarction

✍ Ksenia Goryachkina; Aleksandra Burbello; Svetlana Boldueva; Svetlana Babak; Ulf 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 244 KB

PCN58 IS CYP2D6 GENETIC TEST IN COMBINAT

PCN58 IS CYP2D6 GENETIC TEST IN COMBINATION WITH HORMONE THERAPY FOR ER+ HORMONE SENSITIVE WOMEN WITH EARLY BREAST CANCER COST-EFFECTIVE?

✍ S. Djalalov; J. Beca; J. Hoch 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB